Whole-genome view of the consequences of a population bottleneck using 2926 genome sequences from Finland and United Kingdom

European Journal of Human Genetics

Volumn 25, Issue 4, 2017, Pages 477-484

  Chheda, Himanshu ^a   Palta, Priit ^a,b   Pirinen, Matti ^a   McCarthy, Shane ^c   Walter, Klaudia ^c   Koskinen, Seppo ^d   Salomaa, Veikko ^d   Daly, Mark ^e,f,g   Durbin, Richard ^c   Palotie, Aarno ^a,e,f   Aittokallio, Tero ^a,h   Ripatti, Samuli ^a,c  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF TARTU   (Estonia)

^c WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^d NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^g HARVARD MEDICAL SCHOOL   (United States)

^h UNIVERSITY OF TURKU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

LOW DENSITY LIPOPROTEIN;

ARTICLE; ASPARTYLGLYCOSAMINURIA; BOTTLENECK POPULATION; BRITON; CONTROLLED STUDY; ENHANCER REGION; FINLAND; FINN (PEOPLE); GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; INTRACRANIAL ANEURYSM; LOSS OF FUNCTION MUTATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROMOTER REGION; QUANTITATIVE TRAIT; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; UNITED KINGDOM; WHOLE GENOME SEQUENCING; CONSERVED SEQUENCE; GENETIC POLYMORPHISM; GENETICS; GENOME-WIDE ASSOCIATION STUDY; HUMAN GENOME; MUTATION RATE; POPULATION; STANDARDS;

CONSERVED SEQUENCE; FINLAND; GENOME, HUMAN; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MUTATION RATE; POLYMORPHISM, GENETIC; POPULATION; UNITED KINGDOM;

EID: 85011296312     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2016.205     Document Type: Article

References (37)

1. Lim ET, Wurtz P, Havulinna AS et al: Distribution and medical impact of loss-offunction variants in the Finnish founder population. PLoS Genet 2014; 10: e1004494.
2. Sidore C, Busonero F, Maschio A et al: Genome sequencing elucidates Sardinian genetic architecture and augments association analyses for lipid and blood inflammatory markers. Nat Genet 2015; 47: 1272-1281.
3. Gudbjartsson DF, Helgason H, Gudjonsson SA et al: Large-scale whole-genome sequencing of the Icelandic population. Nat Genet 2015; 47: 435-444.
4. Casals F, Hodgkinson A, Hussin J et al: Whole-exome sequencing reveals a rapid change in the frequency of rare functional variants in a founding population of humans. PLoS Genet 2013; 9: e1003815.
5. Goldstein DB, Allen A, Keebler J et al: Sequencing studies in human genetics: design and interpretation. Nat Rev Genet 2013; 14: 460-470.
6. Kryukov GV, Pennacchio LA, Sunyaev SR: Most rare missense alleles are deleterious in humans: implications for complex disease and association studies. Am J Hum Genet 2007; 80: 727-739.
7. Pritchard JK: Are rare variants responsible for susceptibility to complex diseases? Am J Hum Genet 2001; 69: 124-137.
8. Jakkula E, Rehnstrom K, Varilo T et al: The genome-wide patterns of variation expose significant substructure in a founder population. Am J Hum Genet 2008; 83: 787-794.
9. Kittles RA, Perola M, Peltonen L et al: Dual origins of Finns revealed by Y chromosome haplotype variation. Am J Hum Genet 1998; 62: 1171-1179.
10. Varilo T, Laan M, Hovatta I, Wiebe V, Terwilliger JD, Peltonen L: Linkage disequilibrium in isolated populations: Finland and a young sub-population of Kuusamo. Eur J Hum Genet 2000; 8: 604-612.
11. Service S, DeYoung J, Karayiorgou M et al: Magnitude and distribution of linkage disequilibrium in population isolates and implications for genome-wide association studies. Nat Genet 2006; 38: 556-560.
12. Peltonen L, Jalanko A, Varilo T: Molecular genetics of the Finnish disease heritage. Hum Mol Genet 1999; 8: 1913-1923.
13. Stoll G, Pietilainen OP, Linder B et al: Deletion of TOP3beta, a component of FMRPcontaining mRNPs, contributes to neurodevelopmental disorders. Nat Neurosci 2013; 16: 1228-1237.
14. Vartiainen E, Laatikainen T, Peltonen M et al: Thirty-five-year trends in cardiovascular risk factors in Finland. Int J Epidemiol 2010; 39: 504-518.
15. McCarthy S, Das S, Kretzschmar W et al: A reference panel of 64,976 haplotypes for genotype imputation. Nat Genet 2016; 48: 1279-1283.
16. O'Connell J, Sharp K, Shrine N et al: Haplotype estimation for biobank-scale data sets. Nat Genet 2016; 48: 817-820.
17. Kent WJ, Sugnet CW, Furey TS et al: The human genome browser at UCSC. Genome Res 2002; 12: 996-1006.
18. Harrow J, Frankish A, Gonzalez JM et al: GENCODE: the reference human genome annotation for The ENCODE Project. Genome Res 2012; 22: 1760-1774.
19. McLaren W, Pritchard B, Rios D, Chen Y, Flicek P, Cunningham F: Deriving the consequences of genomic variants with the Ensembl API and SNP Effect Predictor. Bioinformatics 2010; 26: 2069-2070.
20. Adzhubei IA, Schmidt S, Peshkin L et al: A method and server for predicting damaging missense mutations. Nat Methods 2010; 7: 248-249.
21. Trynka G, Sandor C, Han B et al: Chromatin marks identify critical cell types for fine mapping complex trait variants. Nat Genet 2013; 45: 124-130.
22. Lindblad-Toh K, Garber M, Zuk O et al: A high-resolution map of human evolutionary constraint using 29 mammals. Nature 2011; 478: 476-482.
23. Ward LD, Kellis M: Evidence of abundant purifying selection in humans for recently acquired regulatory functions. Science 2012; 337: 1675-1678.
24. Andersson R, Gebhard C, Miguel-Escalada I et al: An atlas of active enhancers across human cell types and tissues. Nature 2014; 507: 455-461.
25. Hnisz D, Abraham BJ, Lee TI et al: Super-enhancers in the control of cell identity and disease. Cell 2013; 155: 934-947.
26. Whitfield TW, Wang J, Collins PJ et al: Functional analysis of transcription factor binding sites in human promoters. Genome Biol 2012; 13: R50.
27. Vukcevic D, Hechter E, Spencer C, Donnelly P: Disease model distortion in association studies. Genet Epidemiol 2011; 35: 278-290.
28. Consortium UK, Walter K, Min JL et al: The UK10K project identifies rare variants in health and disease. Nature 2015; 526: 82-90.
29. Finucane HK, Bulik-SulliVan B, Gusev A et al: Partitioning heritability by functional annotation using genome-wide association summary statistics. Nat Genet 2015; 47: 1228-1235.
30. Welter D, MacArthur J, Morales J et al: The NHGRI GWAS Catalog, a curated resource of SNP-trait associations. Nucleic Acids Res 2014; 42: D1001-D1006.
31. Landrum MJ, Lee JM, Benson M et al: ClinVar: public archive of interpretations of clinically releVant variants. Nucleic Acids Res 2016; 44: D862-D868.
32. Kurki MI, Gaal EI, Kettunen J et al: High risk population isolate reveals low frequency variants predisposing to intracranial aneurysms. PLoS Genet 2014; 10: e1004134.
33. Keinan A, Clark AG: Recent explosive human population growth has resulted in an excess of rare genetic variants. Science 2012; 336: 740-743.
34. Coventry A, Bull-Otterson LM, Liu X et al: Deep resequencing reveals excess rare recent variants consistent with explosive population growth. Nat Commun 2010; 1: 131.
35. Trynka G, Westra HJ, Slowikowski K et al: Disentangling the effects of colocalizing genomic annotations to functionally prioritize non-coding variants within complextrait loci. Am J Hum Genet 2015; 97: 139-152.
36. Consortium EP: An integrated encyclopedia of DNA elements in the human genome. Nature 2012; 489: 57-74.
37. Pott S, Lieb JD: What are super-enhancers? Nat Genet 2015; 47: 8-12.